+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Alopecia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Corticosteroids, 5-Alpha Reductase Inhibitors, Vasodilators, JAK Inhibitors, Immunomodulators), By Disease Type (Androgenetic Alopecia, Alopecia Areata, Alopecia Totalis/Universalis, Cicatricial ), By Route of Administration (Topical, Oral, Injectable), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alopecia Drugs Market size is forecast to increase from $8.09 Billion in 2026 to $16.72 Billion in 2034 at a CAGR of 9.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005517
Pages: 211 Pages

Allogeneic Stem Cells Market Size, Share and Growth Outlook, 2026: Analysis By Cell Type (Hematopoietic Stem Cells (HSCs), Mesenchymal Stem Cells (MSCs), Induced Pluripotent Stem Cells (iPSCs), Embryonic Stem Cells (ESCs)), By Source Type (Bone Marrow, Peripheral Blood, Cord Blood & Amniotic Fluid), By Application (Regenerative Medicine & Tissue Engineering, Cancer / Oncology Therapeutics, Cardiovascular Disorders, Drug Discovery & Preclinical Development, Immune & Autoimmune Disorders), By End-User (Hospitals & Transplant Centers, Specialty Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Allogeneic Stem Cells Market size is forecast to increase from $521.7 Million in 2026 to $3508.44 Million in 2034 at a CAGR of 26.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005516
Pages: 225 Pages

Allogeneic Cell Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Stem Cell Therapies , Non-Stem Cell Therapies (Allogeneic), By Cell Source (Umbilical Cord Blood & Placenta, Peripheral Blood, Bone Marrow, Adipose Tissue), By Therapeutic Area (Hematological Disorders & Oncology, Solid Tumor Oncology, Dermatological Disorders & Wound Healing, Autoimmune & Inflammatory Diseases, Cardiovascular & Ischemic Conditions, Acute Graft-Versus-Host Disease (GvHD)), By End-User (Hospitals & Specialty Cancer Centers, Research & Academic Institutes, Ambulatory Surgical Centers (ASCs)) Companies, and Country Forecast, 2021 to 2034

Global Allogeneic Cell Therapy Market size is forecast to increase from $1.75 Billion in 2026 to $10.84 Billion in 2034 at a CAGR of 25.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005515
Pages: 230 Pages

Allergy Relieving Eye Drops Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Antihistamines and Mast Cell Stabilizers , Antihistamines , Mast Cell Stabilizers , Non-Steroidal Anti-Inflammatory Drugs , Corticosteroids, Vasoconstrictors ), By Type of Ocular Allergy (Seasonal and Perennial Allergic Conjunctivitis (SAC , Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC), Giant Papillary Conjunctivitis (GPC)), By Commercial Category (Over-the-Counter (OTC) Eye Drops, Prescription-Based Eye Drops), By Distribution Channel (Retail Pharmacies and Drugstores, Hospital Pharmacies, Online , Optical Stores and Supermarkets) Companies, and Country Forecast, 2021 to 2034

Global Allergy Relieving Eye Drops Market size is forecast to increase from $1.47 Billion in 2026 to $2.21 Billion in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005514
Pages: 210 Pages

Allergy Immunotherapies Market Size, Share and Growth Outlook, 2026: Analysis By Product (Subcutaneous Immunotherapy (SCIT , Sublingual Immunotherapy (SLIT ), By Indication (Allergic Rhinitis , Allergic Asthma, Food Allergies, Insect Venom Allergies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Allergy Immunotherapies Market size is forecast to increase from $2.39 Billion in 2026 to $4.73 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005513
Pages: 224 Pages

Allergy Diagnostics and Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Allergy Diagnostics , Allergy Therapeutics ), By Test Type (In Vitro Tests , In Vivo Tests ), By Allergen Type (Inhaled Allergens , Food Allergens , Drug Allergens , Venom ), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Allergy Diagnostics and Therapeutics Market size is forecast to increase from $39.88 Billion in 2026 to $78.3 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005512
Pages: 219 Pages

Allergy and Autoimmune Disease Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product & Offering (Instruments , Assay Kits & Consumables , Services), By Technology (Immunoassays , Multiplex Assays, Indirect Immunofluorescence , Molecular Diagnostics, Point-of-Care Testing ), By Disease Category (Allergy Diagnostics , Autoimmune Disease Diagnostics ), By Test Type (In-Vivo Tests , In-Vitro Tests ), By End User (Diagnostic Laboratories, Hospitals & Clinics, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Allergy and Autoimmune Disease Diagnostics Market size is forecast to increase from $12.86 Billion in 2026 to $25.81 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005511
Pages: 211 Pages

Allergic Rhinitis Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Drug Class (Antihistamines, Intranasal Corticosteroids, Immunotherapy , Decongestants, Leukotriene Receptor Antagonists), By Dosage Form (Tablets & Capsules, Nasal Sprays, Liquids & Syrups, Nasal Drops & Intraocular Drops), By Prescription Status (Prescription Drugs , Over-the-Counter Drugs ), By Distribution Channel (Hospital Pharmacies, Drugstores & Retail Pharmacies, Online Pharmacies / E-commerce Platforms) Companies, and Country Forecast, 2021 to 2034

Global Allergic Rhinitis Drugs Market size is forecast to increase from $14.29 Billion in 2026 to $24.08 Billion in 2034 at a CAGR of 6.74% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005510
Pages: 213 Pages

Alginate Dressing Market Size, Share and Growth Outlook, 2026: Analysis By Type (Antimicrobial Alginate Dressings , Non-antimicrobial Alginate Dressings), By Product Form (Flat Sheets/Pads, Ropes, Ribbons), By Application (Chronic Wounds , Acute Wounds , Partial Thickness Burns, Cavity Wounds), By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers , Home Healthcare, Long-term Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Alginate Dressing Market size is forecast to increase from $1.18 Billion in 2026 to $1.65 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005509
Pages: 222 Pages

Alexipharmic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Opioid Antagonists, Benzodiazepine Antagonists, Cyanide Antidotes, Heavy-Metal Chelators, Cholinesterase Reactivators), By Application (Opioid Overdose, Alcohol Overdose, Chemical & Industrial Poisoning, Heavy Metal Poisoning, Benzodiazepine Overdose), By Route of Administration (Injectable/Parenteral, Intranasal , Oral), By Distribution Channel (Hospital Pharmacies, Retail & Community Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Alexipharmic Drugs Market size is forecast to increase from $4.31 Billion in 2026 to $6.48 Billion in 2034 at a CAGR of 5.23% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005508
Pages: 225 Pages